Summit Therapeutics
SMMT
#1317
Rank
A$20.86 B
Marketcap
$28.30
Share price
-0.78%
Change (1 day)
833.40%
Change (1 year)

Summit Therapeutics (SMMT) - Cash on Hand

Cash on Hand as of September 2024 : A$0.74 Billion

According to Summit Therapeutics 's latest financial reports the company has A$0.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.27 B-46.64%
2022-12-31A$0.51 B417.32%
2021-12-31A$99.02 M14.64%
2020-12-31A$86.37 M
2019-01-31A$63.69 M28.1%
2018-01-31A$49.72 M-14.21%
2017-01-31A$57.95 M24.12%
2016-01-31A$46.69 M42.1%
2015-01-31A$32.85 M423.16%
2014-01-31A$6.28 M-22.39%
2013-01-31A$8.09 M67.29%
2012-01-31A$4.83 M-41.33%
2011-01-31A$8.24 M-53.15%
2010-01-31A$17.6 M105.66%
2009-01-31A$8.55 M-80.81%
2008-01-31A$44.59 M-50.89%
2007-01-31A$90.8 M69.58%
2006-01-31A$53.54 M-17.42%
2005-01-31A$64.84 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.83 B 146.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.37 B-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA